Clinical trial
16.0040 Ankylosing Spondylitis Study
NCT00356356 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00356356 |
|---|---|
| Title | 16.0040 Ankylosing Spondylitis Study |
| Official title | Open-label, Long-term Extension Study of Etanercept in the Treatment of Patients With Ankylosing Spondylitis Who Participated in Protocol 16.0037 |
| Lead sponsor | Amgen, Industry |
| Collaborators | Immunex Corporation Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ankylosing Spondylitis |
| Intervention type | Drug |
| Interventions | Etanercept |
| Enrollment | 257 |
| Start date | Apr 1, 2002 |
| Primary completion | Aug 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jul 26, 2006 |
| Last update posted | May 14, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: